Inflammation, immunity, and vaccines for Helicobacter infection

Helicobacter, Supplement

Volumn 10, Issue 1, 2005, Pages 21-25

  Permin, Henrik ^a   Andersen, Leif P ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Helicobacter; Immunity; Inflammation; Vaccine

Indexed keywords

GAMMA INTERFERON; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 18; INTERLEUKIN 1BETA;

CELLULAR IMMUNITY; HELICOBACTER INFECTION; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 25844451675     PISSN: 14784041     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00337.x     Document Type: Review

References (40)

1. Del Giudice G, Michetti P. Inflammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 2004;48:23-8.
2. Yamamoto T, Kita M, Ohno T, Iwakura Y, Sekikawa K, Imanishi J. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol Immunol 2004;48:647-54.
3. Lundgren A, Strömberg E, Sjöling A, et al. Mucosal FOXP3-expressing CD4+ CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 2005;73:523-31.
4. Neu B, Rad R, Reindl W, Neuhofer M, Gerhard M, Schepp W, Prinz C. Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains. J Infect Dis 2005;191:571-8.
5. Rahn W, Redline RW, Blanchard TG. Molecular analysis of Helicobacter pylori-associated gastric inflammation in naive versus previously immunized mice. Vaccine 2004;23:807-18.
6. Sebkova L, Pellicano A, Monteleone G, Grazioli B, Guarnieri G, Imeneo M, Pallone F, Luzza F. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect Immun 2004;72:5019-26.
7. Lin SN, Ayada K, Zhao Y, et al. Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells. J Med Microbiol 2005;54:225-33.
8. Day AS, Su B, Ceponis PJ, Jones NL, Yau E, Sieveking D, Sherman PM. Helicobacter pylori infection induces interleukin-18 production in gastric epithelial (AGS) cells. Dig Dis Sci 2004; 49:1830-5.
9. Akhiani AA, Schön K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol 2004;173:3348-56.
10. Monteleone G, Del Vecchio Blanco G, Palmieri G, et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology 2004;126:674-82.
11. Campbell DI, Pearce MS, Parker L, Thomas JE. IgG subclass responses in childhood Helicobacter pylori duodenal ulcer: evidence of T-helper cell type 2 responses. Helicobacter 2004;9:289-92.
12. Campbell DI, Pearce MS, Parker L, Thomas JE, Sullivan PB, Dale A. Immunoglobulin G subclass responses to Helicobacter pylori vary with age in populations with different levels of risk of gastric carcinoma. Clin Diagn Lab Immunol 2004;11: 631-3.
13. Shimizu T, Haruna H, Ohtsuka Y, Kaneko K, Gupta R, Yamashiro Y. Cytokines in the gastric mucosa of children with Helicobacter pylori infection. Acta Paediatr 2004;93:322-6.
14. Isomoto H, Nishi Y, Wang A, Takeshima F, Omagari K, Mizuta Y, Shikuwa S, Murata I, Kohno S. Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 2004;99:1063-8.
15. Hafsi N, Voland P, Schwendy S, Rad R, Reindl W, Gerhard M, Prinz C. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol 2004;173:1249-57.
16. Basu M, Czinn SJ, Blanchard TG. Absence of catalase reduces long-term survival of Helicobacter pylori in macrophage phagosomes. Helicobacter 2004;9:211-6.
17. McGee DJ, Langford ML, Watson EL, Carter JE, Chen YT, Ottemann KM. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun 2005;73:1820-7.
18. Xia HHX, Lam SK, Huang XR, Wong WM, Leung SY, Yuen ST, Lan HY, Wong BCY. Helicobacter pylori infection is associated with increased expression of macrophage migration inhibitory factor by epithelial cells, T cells, and macrophages in gastric mucosa. J Infect Dis 2004;190:293-302.
19. de Paulis A, Prevete N, Fiorentino I, Walls AF, Curto M, Petraroli A, Castaldo V, Ceppa P, Fiocca R, Marone G. Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20). J Immunol 2004;172:7734-43.
20. Klausz G, Buzas E, Scharek P, Tiszlavicz L, Gyulai Z, Fulop AK, Falus A, Mandi Y. Effects of Helicobacter pylori infection on gastric inflammation and local cytokine production in histamine-deficient (histidine decarboxylase knock-out) mice. Immunol Lett 2004;94:223-8.
21. Pellicano R, Touscoz GA, Smedile A, Berrutti M, Saracco G, Repici A, Ponzetto A, Rizzetto M. Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection. Dig Dis Sci 2004;49:395-8.
22. Yan J, Mao YF, Shao ZX. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World J Gastroenterol 2005;11:421-5.
23. Yan J, Mao YF. Construction of a prokaryotic expression system of vacA gene and detection of vacA gene, VacA protein in Helicobacter pylori isolates and ant-VacA antibody in patients' sera. World J Gastroenterol 2004;10:985-90.
24. Moschos SA, Bramwell VW, Somavarapu S, Alpar HO. Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine 2005;23:1923-30.
25. Shi T, Liu WZ, Gao F, Shi GY, Xiao SD. Intranasal CpG- oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Helicobacter 2005;10:71-9.
26. Dzwonek A, Mikula M, Woszczynski M, Hennig E, Ostrowski J. Protective effect of vaccination with DNA of the H. pylori genomic library in experimentally infected mice. Cell Mol Biol Lett 2004;9:483-95.
27. Hatzifoti C, Bajaj-Elliott M, Dorrell N, Anyim M, Prentice MB, Nye KE, Wren B, Morrow WJ. A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and up-regulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice. Vaccine 2004;22: 2651-9.
28. Johansson EL, Bergquist C, Edebo A, Johansson C, Svennerholm AM. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 2004;22:984-90.
29. Yan J, Wang Y, Shao SH, Mao YF, Li HW, Luo YH. Construction of prokaryotic expression system of ltB-ureB fusion gene and identification of the recombinant protein immunity and adjuvanticity. World J Gastroenterol 2004;10:2675-9.
30. Mao YF, Yan J. Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity. World J Gastroenterol 2004;10:977-84.
31. Xu C, Li ZS, Du YQ, Tu ZX, Gong YF, Jin J, Wu HY, Xu GM. Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA. World J Gastroenterol 2005;11:114-7.
32. Metzger WG, Mansouri E, Kronawitter M, Diescher S, Soerensen M, Hurwitz R, Bumann D, Aebischer T, Von Specht BU, Meyer TF. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar Typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 2004;22:2273-7.
33. Fujii R, Morihara F, Fukushima K, Oku T, Hifumi E, Uda T. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease. Biotechnol Bioeng 2004;86:737-46.
34. Liu XL, Li SQ, Liu CJ, Tao HX, Zhang ZS. Antigen epitope of Helicobacter pylori vacuolating cytotoxin A. World J Gastroenterol 2004;10:2340-3.
35. Budd A, Blandin S, Levashina EA, Gibson TJ. Bacterial alpha2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome? Genome Biol 2004;5:R38.
36. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315-23.
37. Mueller A, O'Rourke J, Chu P, Kim CC, Sutton P, Lee A, Falkow S. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci USA 2003;100:1289-94.
38. Rossi G, Ruggiero P, Peppoloni S, et al. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Infect Immun 2004;72:3252-9.
39. Minoura T, Kato S, Otsu S, Kodama M, Fujioka T, Iinuma K, Nishizono A. Influence of age and duration of infection on bacterial load and immune responses to Helicobacter pylori infection in a murine model. Clin Exp Immunol 2005;139:43-7.
40. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004; 53:1235-43.